Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Analysis of new growth promoting black market products.

Krug O, Thomas A, Malerød-Fjeld H, Dehnes Y, Laussmann T, Feldmann I, Sickmann A, Thevis M.

Growth Horm IGF Res. 2018 Aug;41:1-6. doi: 10.1016/j.ghir.2018.05.001. Epub 2018 May 19.

PMID:
29864719
2.

Evaluation of uncertainty sources in the determination of testosterone in urine by calibration-based and isotope dilution quantification using ultra high performance liquid chromatography tandem mass spectrometry.

Pitarch-Motellón J, Roig-Navarro AF, Sancho JV, Ibáñez M, Fabregat-Cabello N, Pozo OJ, Ventura R, García Alonso JI, Rodríguez-González P, González Gago A, Ereño Artabe A, Van Eenoo P, Deventer K, Dehnes Y, Rzeppa S.

J Chromatogr A. 2017 Jul 28;1508:73-80. doi: 10.1016/j.chroma.2017.05.072. Epub 2017 Jun 3.

PMID:
28601363
3.

Terbutaline Accumulates in Blood and Urine after Daily Therapeutic Inhalation.

Krogh N, Rzeppa S, Dyreborg A, Dehnes Y, Hemmersbach P, Backer V, Hostrup M.

Med Sci Sports Exerc. 2017 Jun;49(6):1236-1243. doi: 10.1249/MSS.0000000000001199.

PMID:
28072631
4.

Black market products confiscated in Norway 2011-2014 compared to analytical findings in urine samples.

Hullstein IR, Malerod-Fjeld H, Dehnes Y, Hemmersbach P.

Drug Test Anal. 2015 Nov-Dec;7(11-12):1025-9. doi: 10.1002/dta.1900. Epub 2015 Nov 26.

PMID:
26607218
5.

MAIIA EPO SeLect-a rapid screening kit for the detection of recombinant EPO analogues in doping control: inter-laboratory prevalidation and normative study of athlete urine and plasma samples.

Dehnes Y, Myrvold L, Ström H, Ericsson M, Hemmersbach P.

Drug Test Anal. 2014 Nov-Dec;6(11-12):1144-50. doi: 10.1002/dta.1752. Epub 2014 Nov 24.

PMID:
25421537
6.

Conformational changes in dopamine transporter intracellular regions upon cocaine binding and dopamine translocation.

Dehnes Y, Shan J, Beuming T, Shi L, Weinstein H, Javitch JA.

Neurochem Int. 2014 Jul;73:4-15. doi: 10.1016/j.neuint.2014.02.003. Epub 2014 Feb 24.

7.

Detection of recombinant EPO in blood and urine samples with EPO WGA MAIIA, IEF and SAR-PAGE after microdose injections.

Dehnes Y, Shalina A, Myrvold L.

Drug Test Anal. 2013 Nov-Dec;5(11-12):861-9.

PMID:
24190107
8.

A novel glutamate transporter blocker, LL-TBOA, attenuates ischaemic injury in the isolated, perfused rat heart despite low transporter levels.

Martinov V, Dehnes Y, Holmseth S, Shimamoto K, Danbolt NC, Valen G.

Eur J Cardiothorac Surg. 2014 Apr;45(4):710-6. doi: 10.1093/ejcts/ezt487. Epub 2013 Oct 6.

PMID:
24099732
9.

The density of EAAC1 (EAAT3) glutamate transporters expressed by neurons in the mammalian CNS.

Holmseth S, Dehnes Y, Huang YH, Follin-Arbelet VV, Grutle NJ, Mylonakou MN, Plachez C, Zhou Y, Furness DN, Bergles DE, Lehre KP, Danbolt NC.

J Neurosci. 2012 Apr 25;32(17):6000-13. doi: 10.1523/JNEUROSCI.5347-11.2012.

10.

Doping analysis on solid ground.

Hemmersbach P, Drange M, Rabin O, Botrè F, Dehnes Y.

Tidsskr Nor Laegeforen. 2012 Jan 24;132(2):130. doi: 10.4045/tidsskr.11.1330. English, Norwegian. No abstract available.

11.
12.

Rapid affinity purification of erythropoietin from biological samples using disposable monoliths.

Lönnberg M, Dehnes Y, Drevin M, Garle M, Lamon S, Leuenberger N, Quach T, Carlsson J.

J Chromatogr A. 2010 Nov 5;1217(45):7031-7. doi: 10.1016/j.chroma.2010.09.034. Epub 2010 Sep 17.

PMID:
20926083
13.

Erythropoietin (EPO) immunoaffinity columns--a powerful tool for purifying EPO and its recombinant analogues.

Dehnes Y, Lamon S, Lönnberg M.

J Pharm Biomed Anal. 2010 Dec 1;53(4):1028-32. doi: 10.1016/j.jpba.2010.06.017. Epub 2010 Jun 26.

PMID:
20656433
14.

A quantitative assessment of glutamate uptake into hippocampal synaptic terminals and astrocytes: new insights into a neuronal role for excitatory amino acid transporter 2 (EAAT2).

Furness DN, Dehnes Y, Akhtar AQ, Rossi DJ, Hamann M, Grutle NJ, Gundersen V, Holmseth S, Lehre KP, Ullensvang K, Wojewodzic M, Zhou Y, Attwell D, Danbolt NC.

Neuroscience. 2008 Nov 11;157(1):80-94. doi: 10.1016/j.neuroscience.2008.08.043. Epub 2008 Aug 27.

15.

Specificity of antibodies: unexpected cross-reactivity of antibodies directed against the excitatory amino acid transporter 3 (EAAT3).

Holmseth S, Dehnes Y, Bjørnsen LP, Boulland JL, Furness DN, Bergles D, Danbolt NC.

Neuroscience. 2005;136(3):649-60.

PMID:
16344142
16.

Glutamate transporters in the guinea-pig cochlea: partial mRNA sequences, cellular expression and functional implications.

Rebillard G, Ruel J, Nouvian R, Saleh H, Pujol R, Dehnes Y, Raymond J, Puel JL, Devau G.

Eur J Neurosci. 2003 Jan;17(1):83-92.

PMID:
12534971
17.

Evaluation of drugs acting at glutamate transporters in organotypic hippocampal cultures: new evidence on substrates and blockers in excitotoxicity.

O'Shea RD, Fodera MV, Apricó K, Dehnes Y, Danbolt NC, Crawford D, Beart PM.

Neurochem Res. 2002 Feb;27(1-2):5-13.

PMID:
11926276
18.

The high-affinity glutamate transporters GLT1, GLAST, and EAAT4 are regulated via different signalling mechanisms.

Gegelashvili G, Dehnes Y, Danbolt NC, Schousboe A.

Neurochem Int. 2000 Aug-Sep;37(2-3):163-70.

PMID:
10812201
19.

Hippocampal GABA and glutamate transporter immunoreactivity in patients with temporal lobe epilepsy.

Mathern GW, Mendoza D, Lozada A, Pretorius JK, Dehnes Y, Danbolt NC, Nelson N, Leite JP, Chimelli L, Born DE, Sakamoto AC, Assirati JA, Fried I, Peacock WJ, Ojemann GA, Adelson PD.

Neurology. 1999 Feb;52(3):453-72.

PMID:
10025773
20.

Properties and localization of glutamate transporters.

Danbolt NC, Chaudhry FA, Dehnes Y, Lehre KP, Levy LM, Ullensvang K, Storm-Mathisen J.

Prog Brain Res. 1998;116:23-43. Review. No abstract available.

PMID:
9932368
21.

Localization of transporters using transporter-specific antibodies.

Danbolt NC, Lehre KP, Dehnes Y, Chaudhry FA, Levy LM.

Methods Enzymol. 1998;296:388-407. No abstract available.

PMID:
9779462
22.

Supplemental Content

Loading ...
Support Center